-
Finance Sector Scorecard and Analyst Reports for Pfizer, Accenture & Wells Fargo
Tuesday, April 18, 2023 The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features a real-time update on the onoging Q1 earnings season, particularly the Finance sector, and new research reports on 16 major stocks, including Pfizer Inc. (PFE), Accenture plc (ACN) and Wells Fargo & Company (WFC). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. You can see all of today’s research reports here >>> Finance Sector Scorecard Including this morning’s results, we now have Q1 results from 40 S&P 500 members that combined account for 11.4{9f99fe44fce1aa3c813d0a0ce4da2fbea8a5a58e9d85c4a2927dd8140cb676b5} of the index’s total market capitalization.…
-
Investing in Cedar Fair: A Look at Financial Analyst Reports and Market Trends
Cedar Fair, L.P. (NYSE:FUN), the renowned amusement park operator has been closely monitored by Bloomberg Ratings, which confirms that ten financial analysts are currently tracking the firm’s performance. As per their reports, out of those ten analysts, two have nominated Cedar Fair stock as a hold, three as a purchase, and the rest five as moderate buy recommendations. The average prediction of the one-year target price of this stock among diverse brokerages who have recently updated their stock coverage is $53.13 with an overall market cap of $2.34 billion. Cedar Fair LP operates acclaimed amusement parks across the US such as Cedar Point, Kings Island, Canada’s Wonderland, Dorney Park and…
-
SomaLogic Reports Fourth Quarter and Full Year 2022 Financial Results, Announces Director Appointments and Management Evolution
SomaLogic Adam Taich, EVP Life Sciences, promoted to interim CEO with a focus on operational execution Board transition adds industry veterans: Jason Ryan as Chairman; Tycho Peterson, Kathy Hibbs, and Tom Carey as Independent Directors Fourth quarter 2022 revenue of $18.8 million; full year 2022 revenue of $97.7 million Full year 2023 revenue guidance of $80-84 million, reflecting 12-17{9f99fe44fce1aa3c813d0a0ce4da2fbea8a5a58e9d85c4a2927dd8140cb676b5} growth over 2022, excluding licensing revenue from New England Biolabs Substantial balance sheet provides flexibility with cash and investments of $539.6 million at year-end 2022 Working with advisors to pursue offensive strategic options including transformational opportunities Management to host a conference call today at 4:30 pm ET. BOULDER, Colo., March 28,…
:format(url)/cloudfront-us-east-1.images.arcpublishing.com/baltimorebanner/EFU7D5KNL5CVJGENTPUI2SFB5E.jpg "Former mayor candidate served on Silicon Valley Bank board")
